O'Keeffe Charles B's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 17, 2022
- Accession no.
- 0001161697-22-000554
- Filed
- Nov 17, 2022
- Trade date
- Nov 15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.41M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Keeffe Charles BCIK 0001378656 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common stock, par value $0.001 per share | SSaleAcquired | +87,985 | $16.04 | +$1,411,279.4 | 565,057 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.